NBNorman Balcazar

Norman Balcazar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Norman Balcazar has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preclinical evaluation of a natural extract-based oral nanoformulation from Eucalyptus tereticornis for potential use in treating type 2 diabetes mellitus

    by Natalia Arbeláez, Elkin Escobar-Chaves, Andrea Correa, Adriana Restrepo, Sergio Acin, Jahir Orozco, Norman Balcazar

    The acute, subacute, and subchronic oral toxicities, as well as the combined chronic toxicity and carcinogenicity, of a nanotechnology-based formulation derived from a natural extract of Eucalyptus tereticornis leaves were investigated. This nanoformulation demonstrates anti-obesogenic and potentially anti-diabetic properties. Our study aims to conduct preclinical tests to evaluate the chemical formulation. To assess acute toxicity, rats received a single oral dose of 2000 mg/kg of the nanoformulation. In the subacute trial, mice were treated with approximately 1180 mg/kg of the nanoformulation for 28 days. In the combined chronic toxicity and carcinogenicity study, the nanoformulation was administered daily at approximately 590 mg/kg for 10 months. At the end of the experiment, hematological, biochemical, and histopathological assessments were conducted. Throughout the acute, subacute, subchronic, and chronic/carcinogenicity studies, animals showed no toxic effects from the treatment or the vehicle. No histopathological lesions, such as degeneration or cell death in the liver, kidney, or gastrointestinal tract, were observed. Treatments did not cause any clinical changes, and there were no significant differences in weight, hematological, or biochemical parameters. Therefore, the nanoformulation did not produce toxic effects in the animals.

  • Open Access

    Low-toxicity aqueous and ethanolic extracts of Stevia rebaudiana Bertoni increase glucose uptake and modulate lipid metabolism and inflammation in key metabolic cell models of obesity and type 2 diabetes

    by Sergio Acin, Valentina Mora, Helen Cardona, Carlos Peláez, Norman Balcazar, Nora Restrepo–Sánchez, Diana Lorena Muñoz

    Obesity is a chronic disease that leads to an increased risk for insulin resistance and diabetes, increasing the risk of mortality and morbidity. Natural sweeteners are an alternative in energy management reducing calorie intake. In this work, we have evaluated the bioactivity of extracts of Stevia rebaudiana Bertoni grown in the department of Antioquia, Colombia. Adipocytes, hepatocytes, myocytes, macrophages, and pancreatic cells, key cellular models involved in development of obesity and diabetes, were used to show that ethanolic and aqueous extracts of this plant have the advantage of low toxicity and reduce triglyceride content in hepatocytes and adipocytes, modulating the expression of genes involved in lipogenesis and adipogenesis. These extracts also increase glucose uptake in both insulin resistant and non-resistant muscle cells and present anti-inflammatory properties in the macrophage model. The range of biological activities demonstrated in vitro indicates that Stevia, beyond its natural sweetness, may improve metabolic disorders associated with obesity and T2DM.

  • Open Access

    Study of insulin infusion in diabetic rats with an ultra‐low‐cost insulin pump for managing blood glucose levels

    by Jhon E. Goez‐Mora, Natalia Arbelaez‐Córdoba, Norman Balcazar‐Morales, Pablo S. Rivadeneira

    Introduction: This study assesses the accuracy of an ultra‐low‐cost insulin pump for regulating blood glucose, an essential component of the artificial pancreas. Objectives: The primary objective is to assess the accuracy of blood glucose regulation using an ultra‐low‐cost insulin pump compared with insulin injections. Methods: The study was conducted using 14 male Wistar rats aged 14 weeks, which were induced with diabetes through a streptozotocin procedure. The control group (seven subjects) was treated with subcutaneous insulin injections, and the study group (seven subjects) was treated with the experimental insulin pump. Results: Our findings reveal that the ultra‐low‐cost insulin pump performs comparably to insulin injections for glycemia regulation using standard clinical insulin treatment. The blood glucose records obtained by CGM indicate that trends in both methods correspond, with a glycemia median absolute relative difference of 6.1748 mg/dL and an interquartile range of 14.57 mg/dL. The response time to reach glucose levels between 70 and 180 mg/dL was around 55 min, testing different amounts of insulin units ranging from 0.09 to 2.06 U. Also, four obstruction cases were detected by the system in an average time of 3 s, showing compliance with the EN60601‐2‐24 standard. Conclusions: The in vivo experiments with diabetic rats and ultra‐low‐cost insulin pumps demonstrate that these prototypes can be used for glucose regulation in clinical trials while complying with the conditions of the EN60601‐2‐24 standard. Future work should focus on conducting insulin pump tests in a closed loop and a cybersecurity study to prevent any possible external attack.


  • Open Access

    A triterpene-enriched natural extract from Eucalyptus tereticornis modulates the expression of genes involved in adipogenesis, lipolysis, and extracellular matrix remodeling in a primary human and mouse cell line adipocyte

    by Sergio Acin, Alejandro Mejia-Garcia, Geysson Javier Fernandez, Norman Balcazar

    Obesity induces alterations in adipocyte size, tissue inflammation, vascularization, and extracellular matrix composition. Previous studies have shown that a leaf extract of Eucalyptus tereticornis Sm. (Myrtaceae), with ursolic acid, oleanolic acid, and ursolic acid lactone mixed with minor metabolites, provided a superior antiobesity effect than reconstituted triterpenoid mixtures in adipocyte cell lines and a pre-diabetic mouse model. Further identification of the molecular mechanisms of action of this mixture of triterpenes is required. This study analyzes the effect of the natural extract and its components on early RNA expression profiles in human primary cultured adipocytes and a mouse cell line. RNA was sequenced using the DNBseq platform and the EnrichR software to perform gene enrichment analysis using the Gene Ontology database, Kyoto Encyclopedia of Genes and Genomes, and Reactome. To conduct clustering analysis, the normalized counts of each gene and applied k-means clustering were standardized. The combination of molecules in the natural extract has an additive or synergic effect that increases the number of genes regulated associated with the biological functionality of differentiating adipocytes, with UAL playing a central role. The natural extract modulates PPAR, Wnt, and Extracellular Matrix organization pathways significantly in both cellular models. Remarkably, the extract downregulates the expression of genes involved in lipid metabolism, adipogenesis, and adipocyte fat load, such as PRKAR2B, LPIN1, FABP4, Scd1, MC5R, CD36, PEG10, and HMGCS1. Our study shows that Eucalyptus tereticornis extract is a promising option for treating adipocyte tissue dysfunction derived from obesity.


  • Open Access

    Cecropia angustifolia Pentacyclic Triterpene Acids and Sacha Inchi Oil Improve Carbohydrate Metabolism and Inflammation in Prediabetic Mice

    by Johanna Valentina Lopez-Cortes, Sergio Acin-Martinez, Guillermo Montoya, Norman Balcazar

    Type 2 diabetes mellitus is closely linked with obesity and associated metabolic dysfunctions, including insulin resistance, dyslipidemia, and chronic inflammation. Pentacyclic triterpene acids (PTAs) derived from Cecropia angustifolia are promising bioactive compounds that may help mitigate these disorders. This study investigated the effects of a PTA‐rich fraction on metabolic disruptions in cellular and diet‐induced obesity mouse models. Prediabetic C57BL/6J mice fed on high‐fat diet (HFD) for 8 weeks exhibited typical metabolic abnormalities, such as increased body weight, glucose intolerance, hyperinsulinemia, and dyslipidemia, which served as a baseline for assessing PTA efficacy. 8‐week treatment with C. angustifolia PTAs showed significant improvement in glucose metabolism, enhancing insulin sensitivity and glucose tolerance and reducing plasma insulin levels. Although PTAs did not alter body weight or lipid profiles in HFD‐fed mice in a sacha inchi oil (SIO) vehicle, they effectively prevented further weight gain, especially with intraperitoneal administration. Interestingly, we found that SIO, used as PTA solubilizer, yielded similar hypoglycemic and anti‐inflammatory outcomes, and coadministration did not yield additive or synergistic effects. Furthermore, both PTAs and SIO demonstrated in vitro anti‐inflammatory activity by downregulating proinflammatory gene expression, and no adverse liver, kidney, and pancreas toxicity was observed. In conclusion, PTAs from Cecropia angustifolia and SIO present potential as nontoxic, bioactive agents for modulating carbohydrate metabolism and inflammation in obesity‐related conditions, although further studies are warranted to optimize dosing and investigate SIO’s standalone therapeutic potential.


  • Open Access

    Encapsulation of Eucalyptus tereticornis extract in polylactic-co-glycolic acid nanoparticles: standardization, optimization and cell viability

    by Maria C. Cely-Garcia, Diana Y. Espinel-Pabón, Nancy Jaimes-Mendez, Norman Balcazar-Morales, Edwin A. Murillo-Ruiz

    Eucalyptus tereticornis extract is a promising drug for the treatment of type 2 diabetes mellitus and obesity, showing in vitro effects, such as increased glucose uptake and reduced lipid storage. However, its in vivo efficacy has been demonstrated only when administered intraperitoneally. Thus, this study focused on standardisation and optimisation of the preparation of polylactic-co-glycolic acid 50:50 nanoparticles (NPs). The size distribution of the NPs, polydispersity index, and zeta potential were evaluated to identify the NPs with the best encapsulation efficiency and loading capacity based on a first-order design using the response surface methodology. To evaluate cell viability of the NPs, in vitro viability assessments were performed using C2C12, 3T3-L1, HepG2, and J774A.1 cell lines and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The highest encapsulation efficiency and load capacity were 81.569 ± 1.798% and 1.885 ± 0.042%, respectively. These results confirmed the effective encapsulation of Eucalyptus tereticornis extract and the interactions between the components of the system. Finally, none of the evaluated concentrations negatively affected the cell line viability, confirming the reproducibility of the method with great pharmacological potential. In addition, this model can be used to develop nanoformulations that efficiently improve response.


  • Open Access

    RNA-seq analysis reveals modulation of inflammatory pathways by an enriched-triterpene natural extract in mouse and human macrophage cell lines

    by Alejandro Mejia-Garcia, Geysson Javier Fernandez, Luis Fernando Echeverri, Norman Balcazar, Sergio Acin


  • Open Access

    Elucidating the antioxidant action mechanism of a phytotherapeutic released from polymeric nanoparticles by diamond magnetometry

    by Elkin Escobar-Chaves, Arturo Llumbet, Alina Sigaeva, Claudia Reyes, Norman Balcazar, Jahir Orozco, Romana Schirhagl

  • Open Access

    Polymeric nanoformulation prototype based on a natural extract for the potential treatment of type 2 diabetes mellitus

    by Elkin Escobar-Chaves, Sergio Acin, Diana Lorena Muñoz, Maritza Fernández, Alexandra Echeverri, Fernando Echeverri, Jahir Orozco, Norman Balcázar


  • Open Access

    An experimental and in silico analysis of Lacticaseibacillus paracasei isolated from whey shows an association between lactate production and amino acid catabolism

    by Carlos Eduardo Mejía-Gomez, Rigoberto Rios-Estepa, Luis Alberto Gonzalez-Lopez, Norman Balcazar-Morales

    The production of lactic acid from agroindustry waste products, such as whey, heavily relies on microorganisms within the genusLactobacillus. In this work, a genome-scale metabolic model was implemented from Vinay-Lara (iLca334_548), improved adding some enzymatic reactions and used to analyse metabolic fluxes ofLacticaseibacillus paracasei, which is aLactobacillusstrain isolated from whey used in the large-scale production of lactic acid. Overall, the highest rate of lactic acid productivity was 2.9 g l-1h-1, which equates to a dilution rate of 0.125 h-1, when continuous culture conditions were established. Restrictions on lactic acid production caused by exchange reactions, complex culture medium and intracellular metabolite concentrations were considered and included in the model. In total, theiLca334_548 model consisted of 1046 reactions and 959 metabolites, and flow balance analysis better predicted lactate flux than biomass. The distribution of fluxes exhibited an increase in lactate formation as biomass decreased. This finding is supported by the reactions carried out by glyceraldehyde 3-phosphate dehydrogenase, pyruvate formate lyase and ribose-5-phosphate isomerase, corroborating the modelled phenotype with experimental data. In conclusion, there is potential for the improvement of lactate production in a complex media by amino acid catabolism, especially when lactate is derived from pyruvate.